Literature DB >> 10506121

Recurrent alterations of the short arm of chromosome 3 define a tumor suppressor region in rat mammary tumor cells.

N C Popescu1, J W Greiner.   

Abstract

Cytogenetic alterations associated with different stages in carcinogenesis can be distinguished in cultured human or rodent cells transformed by carcinogenic agents. Three tumorigenic rat mammary epithelial cell lines transformed in vitro with 7,12, -dimethylbenz[a]anthracene alone or in combination with 12-O-tetradecanoylphorbol-13-acetate were examined cytogenetically. Non-random alterations consisting of translocations involving the short arm of chromosome 3 and trisomy of chromosomes 14 and X were identified in all three lines. Deletion and inversion of chromosome 1 with the breakpoint at band 1q22 and a duplication 1q 32-43 and trisomy of chromosome 2 were observed in two cell lines. The accumulation of structural alterations and chromosome imbalances during the process of cell immortalization and acquisition of tumorigenicity are required for normal rat mammary cells to become malignant. Unbalanced translocations of chromosome 3 resulting in loss of the short arm had the breakpoint at 3p11. This site is a hotspot of breakage and recombination in various rat tumors and may represent a region of tumor suppressor gene critical to the development of rat mammary tumors, as well as other types of tumors.

Entities:  

Mesh:

Year:  1999        PMID: 10506121     DOI: 10.1093/carcin/20.10.2033

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  2 in total

1.  SKY analysis revealed recurrent numerical and structural chromosome changes in BDII rat endometrial carcinomas.

Authors:  Eva Falck; Carola Hedberg; Karin Klinga-Levan; Afrouz Behboudi
Journal:  Cancer Cell Int       Date:  2011-06-27       Impact factor: 5.722

2.  Defining the sister rat mammary tumor cell lines HH-16 cl.2/1 and HH-16.cl.4 as an in vitro cell model for Erbb2.

Authors:  Sandra Louzada; Filomena Adega; Raquel Chaves
Journal:  PLoS One       Date:  2012-01-10       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.